NCT04389320View on ClinicalTrials.gov

Antimalarial and Covid 19 in Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

May 1, 2020

Study Completion Date

May 1, 2020

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Hydroxychloroquine

assess its role in the coarse of covid 19 virus infection

Trial Locations (1)

7111

Manal Hassanien, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04389320 - Antimalarial and Covid 19 in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter